- Home
- NBIX vs INVH Comparison
NBIX vs INVH Comparison
Compare NBIX & INVH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NBIX | INVH |
|---|---|---|
| Founded | 1992 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.9B | 16.2B |
| IPO Year | 1996 | 2016 |
Fundamental Metrics
Financial Performance| Metric | NBIX | INVH |
|---|---|---|
| Price | $130.69 | $25.03 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 22 | 18 |
| Target Price | ★ $175.27 | $32.44 |
| AVG Volume (30 Days) | 901.1K | ★ 6.2M |
| Earning Date | 05-04-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 4.81% |
| EPS Growth | ★ 41.95 | 29.73 |
| EPS | ★ 4.67 | 0.96 |
| Revenue | $161,626,000.00 | ★ $2,729,296,000.00 |
| Revenue This Year | $22.85 | $3.43 |
| Revenue Next Year | $9.99 | $3.09 |
| P/E Ratio | $27.99 | ★ $26.07 |
| Revenue Growth | ★ 977.51 | 4.21 |
| 52 Week Low | $84.23 | $24.87 |
| 52 Week High | $160.18 | $35.80 |
Technical Indicators
Market Signals| Indicator | NBIX | INVH |
|---|---|---|
| Relative Strength Index (RSI) | 48.44 | 38.04 |
| Support Level | $128.03 | N/A |
| Resistance Level | $136.74 | $27.65 |
| Average True Range (ATR) | 2.86 | 0.49 |
| MACD | 0.33 | -0.08 |
| Stochastic Oscillator | 47.92 | 7.78 |
Price Performance
Historical ComparisonAbout NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.
About INVH Invitation Homes Inc.
Invitation Homes owns a portfolio of over 85,000 single-family rental homes. The company focuses on owning homes in the starter and move-up segments of the housing market with an average sale price around $350,000 and generally less than 1,800 square feet. The portfolio is spread across 17 target markets that feature high employment and household formation growth with over 70% of the portfolio in the Western US and Florida; 15 of the 17 markets featuring average rents lower than homeownership costs.